Ankyrin repeat binding proteins and their uses
US11466062B2 · kind B2 · utility
0Cited by
12References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2021 |
| Grant date | Oct 11, 2022 |
| Priority date | — |
| Expiry date | May 6, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2318/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to recombinant binding proteins comprising one or more designed ankyrin repeat domains with binding specificity for coronavirus spike proteins, nucleic acids encoding such proteins, pharmaceutical compositions comprising such proteins or nucleic acids, and the use of such proteins, nucleic acids or pharmaceutical compositions in the treatment of coronavirus diseases, particularly diseases caused by SARS-CoV-2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.